Comparative clinical response, safety, and institutional drug use efficiency of intravenous azithromycin versus erythromycin in pediatric Mycoplasma pneumoniae pneumonia: a real-world evidence study
ObjectiveThis study aims to compare real-world clinical response, safety, and institutional medication efficiency of intravenous (IV) azithromycin (AZI) versus erythromycin lactobionate (ERY) in hospitalized children with Mycoplasma pneumoniae pneumonia (MPP).MethodsA retrospective cohort of 1,049 c...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2026-02-01
|
| Series: | Frontiers in Cellular and Infection Microbiology |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fcimb.2026.1782840/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|